We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > CALD

News List

Minaris Will Be the Commercial Manufacturer in Europe for Skysona™, bluebird bio’s Gene Therapy for CALD b3cnewswire
July 22, 2021
Minaris Regenerative Medicine GmbH (“Minaris”), a leading contract development and manufacturing organization (CDMO) for the cell and gene therapy industry, will be the commercial manufacturer in Europe for Skysona™ (elivaldogene autotemcel, Lenti-D™), a
CHMP puts eight new medicines forward for EU approval pharmatimes
May 25, 2021
An investigational pneumococcal conjugate vaccine (PCV) candidate, developed by MSD, has achieved positive topline results in a Phase III paediatric study.
bluebird bio releases new data on its gene therapy for cerebral adrenoleukodystrophy europeanpharmaceuticalreview
March 17, 2021
Data from nearly seven years of follow up suggests one-time treatment with eli-cel may durably stabilise cerebral adrenoleukodystrophy disease progression.